¼¼°èÀÇ °í·ÉÀÚ¿ë ÀǾàǰ ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Ä¡·áÁ¦º°, º´Åº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)
Geriatric Medicine Market Size, Share & Trends Analysis Report By Therapeutics (Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors), By Condition, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1530006
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,464,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,887,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,732,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³ëÀοë ÀǾàǰ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ³ëÀοë ÀǾàǰ ½ÃÀå ±Ô¸ð´Â 2024-2030³â¿¡ °ÉÃÄ CAGR 7.5%¸¦ ±â·ÏÇßÀ¸¸ç, 2030³â±îÁö 2,600¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ¼¼°è ÀÇ·á »ê¾÷°ú Á¤ºÎ¿¡ Å« °úÁ¦ Áß ÇϳªÀÌÁö¸¸, ³ëÀÎ ÀǾàǰ ½ÃÀå¿¡ ÇýÅÃÀÌ ÀÖÀ½ÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù.

³ëÀÎ Àα¸¿¡¼­ ´Ù¾çÇÑ ´ë»ó ÁúȯÀÇ À¯º´·ü »ó½Â, Àα¸ ¿ªÇÐ º¯È­, ¶óÀÌÇÁ ½ºÅ¸Àϰú °ü·ÃµÈ À§Çè ¿äÀÎ Áõ°¡ Ãß¼¼, ½ÅÈï °æÁ¦ ±¹°¡ÀÇ ÀÇ·á»Ó¸¸ ¾Æ´Ï¶ó Àú·ÅÇÑ ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¾×¼¼½º°¡ Å©°Ô °³¼± µîÀ¸·Î ³ôÀº ½ÃÀå ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

³ëÀÎ Àα¸¿¡¼­ ¾ËÃ÷ÇÏÀÌ¸Ó º´ÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀº ¿¹Ãø ±â°£ µ¿¾È ³ëÀÎ ÀǾàǰ ½ÃÀåÀÇ ¿µÇâ·ÂÀÌ °­ÇÑ ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2015³â Alzheimer's disease InternationalÀÌ ¹ßÇ¥ÇÑ ÃßÁ¤¿¡ µû¸£¸é ¾à 4,700¸¸ ¸íÀÌ Ä¡¸Å¸¦ ¾Î°í ÀÖÀ¸¸ç, ÀÌ ¼ö´Â 20³â¸¶´Ù µÎ¹è·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´õ¿íÀÌ The Alzheimer's AssociationÀÌ ¹ßÇ¥ÇÑ ÃßÁ¤¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 540¸¸¸íÀÇ ¹Ì±¹ÀÎ Áß ¾à 520¸¸¸í(96.3%)ÀÌ 65¼¼ ÀÌ»óÀÇ ³ëÀÎÀÔ´Ï´Ù.

¿¬·É, »ýȰ¾ç½Ä, °æÁ¦¹ßÀü µî Àα¸Åë°èÀû º¯¼öÀÇ ¹Ù¶÷Á÷ÇÏÁö ¾ÊÀº º¯È­¿Í °í·ÉÀÚ Àα¸¿Í °ü·ÃµÈ Áúº´ µ¿ÇâÀÇ »óÇâ À̵¿ÀÌ ÇÔ²² ¹ß»ýÇÏ´Â ¿ì·Á¸¦ °æ°¨Çϱâ À§ÇØ ¼±Áø Áö¿ªÀº ÀϰüµÇ°Ô ÀÇ·á¿Í »çȸ °³¹ß ºÎ¼­¿¡ ¸¹Àº ¾çÀÇ ÀÚ¿øÀ» ÇÒ´çÇÔÀ¸·Î½á ÀÇ·á °üÇàÀ» °³¼±ÇØ ¿Ô½À´Ï´Ù.

¿¹¸¦ µé¾î ¹Ì±¹, µ¶ÀÏ, ¿µ±¹, ÀϺ»Àº °¢°¢ GDPÀÇ 17.1%, 11.30%, 9.10%, 10.20%¸¦ ÀÇ·á ÁöÃâ¿¡ Ãæ´çÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ÀÚ¿øÀÇ ´ëºÎºÐÀº ½Å¾à °³¹ß, ½Å ¼ÒÇÁÆ®¿þ¾î °³¹ß, º´¿ø ¹× ÀçÅÃÄ¡·á ¼­ºñ½º¸¦ À§ÇÑ ±â¼ú Ç÷§Æû ±¸Ãà¿¡ Âø¼öÇϰí ÀÖ½À´Ï´Ù.

³ëÀοë ÀǾàǰ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ³ëÀοë ÀǾàǰ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¼¼°èÀÇ °í·ÉÀÚ¿ë ÀǾàǰ ½ÃÀå : Ä¡·áÁ¦, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¼¼°èÀÇ °í·ÉÀÚ¿ë ÀǾàǰ ½ÃÀå : º´ÅÂ, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¼¼°èÀÇ °í·ÉÀÚ¿ë ÀǾàǰ ½ÃÀå : À¯Åë ä³Î, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¼¼°èÀÇ °í·ÉÀÚ¿ë ÀǾàǰ ½ÃÀå :Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Geriatric Medicine Market Growth & Trends:

The global geriatric medicine market size is expected to reach USD 260.0 billion by 2030, registering a CAGR of 7.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increase in the global geriatric population is one of the major challenges for the healthcare industry and the governments across the globe, however, it has proven to be a boon for the geriatric medicine market.

The high market growth is anticipated on account of the rising prevalence of various target diseases in the geriatric population, the demographic shift, the upward trend in lifestyle-related risk factors, and the significantly improved access to affordable healthcare as well as medicine across the developing and emerging economies.

The rising prevalence of the Alzheimer's disease in the geriatric population is expected to serve as a high impact rendering driver for the geriatric medicine market over the forecast period. In 2015, as per the estimates published by the Alzheimer's disease International, nearly 47 million people have dementia and this number is expected to double after every 20 years. Furthermore, as per the estimates published by The Alzheimer's Association, in the U.S., out of the 5.4 million Americans living with the disease, nearly 5.2 million or 96.3% are aged 65 and above.

In order to mitigate the concerns arising due to the unfavorable shift in the demographic variables such as age, lifestyle patterns, economic development, coupled with the upward shift in the disease trends associated with the geriatric population, the developed regions have consistently improved their healthcare practices by allocating high amount of resources towards the healthcare and social development sectors.

For instance, the U.S., Germany, the UK, and Japan allocate 17.1%, 11.30%,9.10%,10.20%, of their GDP respectively towards healthcare expenditure and majority of these resources are channelized towards developing new drugs, new software, and building technology platforms for hospitals and home health services.

Geriatric Medicine Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Global Geriatric Medicine Market Variables, Trends, & Scope

Chapter 4. Global Geriatric Medicine Market: Therapeutics Estimates & Trend Analysis

Chapter 5. Global Geriatric Medicine Market: Condition Estimates & Trend Analysis

Chapter 6. Global Geriatric Medicine Market: Distribution Channel Estimates & Trend Analysis

Chapter 7. Global Geriatric Medicine Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â